Skip to main content

Table 3 Risk factors for Norovirus infection

From: Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study

Variable Univariate analysis Multivariate analysis
Odds ratio [IQR] p (Wald’s test) Odds ratio [IQR] p (Wald’s test)
Diabetes 7.5 [1.7–32.8] 0.007 6.4 [1.2–35] 0.03
Induction therapy with ATG 2.5 [0.49–12.89] 0.273   
Maintenance therapy with CT 1.8 [0.51–2.29] 0.847   
Maintenance therapy with Tac 1.29 [0.64–2.59] 0.481   
Maintenance therapy with CsA 0.5 [0.23–1.07] 0.045 0.34 [0.1–0.9] 0.03
CMV replication 1.3 [0.57–2.96] 0.533   
Serum gammaglobulin level < 6.5 g/L 4.5 [0.97–20.8] 0.054 5.1 [0.96–26.5] 0.055
Lymphocyte count < 1000/mm3 2.14 [0.87–5.2] 0.096 3.8 [1.2–12] 0.02
  1. Abbreviations: ATG Anti-Thymocyte Globulin, CsA Ciclosporin A, CT Corticosteroids, Tac Tacrolimus